glp-1 gastroparesis class action in louisiana spent over $1B on GLP-1s 2023. See U.S. data louisiana semaglutide ileus class action

Prog Neuropsychopharmacol Biol Psychiatry

While state Medicaid programs must cover nearly all Food and Drug Administration (FDA) approved drugs, a long-standing statutory exception allows states to choose whether to cover weight-loss drugs under Medicaid

Discovered in 2015, MOTS-c functions as a signaling molecule that helps the body respond to metabolic stress by improving glucose uptake, enhancing insulin sensitivity, and promoting fat metabolism

These benefits extend well beyond the scale, addressing the metabolic dysfunction that accompanies excess body weight

Some required hospital care

Ultimately, these drugs may prove more effective in preventing cognitive decline or as part of combination therapies, but more research is needed before they can be recommended specifically for Alzheimers